ESR1 and breast cancer: We herein demonstrated that an exogenous E2 treatment and increase in endogenous E2 levels during pregnancy drove the mobilization of MDSC from the BM, directly augmented their immunosuppressive activity via ERα, and facilitated the progression of ERα-negative cervical/breast cancers.